The incidence of malignant mesothelioma, a neoplastic process affecting the pleura, and to a lesser extent the peritoneum, is increasing. Mesothelioma is almost always caused by inhalation of asbestos fibers years before the development of the malignancy. Since asbestos exposure generally occurs on the job site, obtaining a thorough occupational history is critical. The elapsed time between first

READ MORE -

Current surgical management of malignant pleural mesotheliomaMalignant pleural mesothelioma is a rare and very aggressive malignancy with an increasing incidence. Single-modality therapy has failed to improve median survival. Current surgical therapies include palliative and cytoreductive procedures. The rarity of the disease, the lack of randomized surgical studies, and the lack of a universally

READ MORE -

Patients with a cancer of the lining of the lung, known as malignant pleural mesothelioma (MPM), lived longer than previously reported(1), when treated with Eli Lilly and Company's Alimta(®) (pemetrexed) in combination with cisplatin, according to updated data presented at the 11th annual Conference on Lung Cancer (WCLC).Mature data presented at WCLC represent an update from trial results from

READ MORE -